Search research articles
Contact Us
Filters
Showing results (11-20 of 83) with videos related to
Page
of 9
Sort By:
Frontiers in Pharmacology
|
May 29, 2026
Efficacy of combined sodium-glucose cotransporter 2 inhibitors and finerenone in chronic kidney disease: a systematic review and meta-analysis
Chen-Fu Wen, Min-Hsiang Chuang, Vin-Cent Wu, et al.
Geroscience
|
May 8, 2026
Comparative effectiveness of SGLT-2 inhibitors and GLP-1 receptor agonists on the risk of incident dementia after acute kidney injury: a target-trial emulation
Ying-Ru Chen, Zheng-Hong Jiang, Jui-Yi Chen, et al.
Cardiovascular Diabetology
|
July 31, 2024
Mortality and cardiovascular events in diabetes mellitus patients at dialysis initiation treated with glucagon-like peptide-1 receptor agonists
Hsuan-Wen Lai, Chun Yin See, Jui-Yi Chen, et al.
Scientific Reports
|
December 13, 2023
Lower product of magnesium × potassium is associated with higher mortality in chronic hemodialysis patients: a cohort study
Jui-Yi Chen, Ming-Yan Jiang, Yun-Ting Huang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 13, 2024
Enhanced Outcomes in Type 2 Diabetes Patients with Acute Kidney Disease Through Thiazolidinedione
Li-Yang Chang, Hung-Wei Liao, Jui-Yi Chen, et al.
Cardiovascular Diabetology
|
March 8, 2025
Potential benefits of GLP-1 receptor agonist in dialysis patients with type 2 diabetes: the need for comprehensive pharmacokinetic and hemodialysis analyses
Hsuan-Wen Lai, Jui-Yi Chen, Vin-Cent Wu, et al.
Kidney Research and Clinical Practice
|
February 5, 2026
Medical treatment for diabetic acute kidney disease from 2012 to 2024: advances, prescription trends, and future directions
Heng-Chih Pan, Chung-An Wang, Jui-Yi Chen, et al.
Diabetes Research and Clinical Practice
|
June 28, 2025
Clinical outcomes in people with type 2 diabetes and acute kidney disease: combined SGLT2i and GLP-1RA therapy vs. monotherapy
Jui-Yi Chen, Min-Hsiang Chuang, Hsuan-Wen Lai, et al.
International Journal of Molecular Sciences
|
February 10, 2024
From Acute to Chronic: Unraveling the Pathophysiological Mechanisms of the Progression from Acute Kidney Injury to Acute Kidney Disease to Chronic Kidney Disease
Tzu-Hsuan Yeh, Kuan-Chieh Tu, Hsien-Yi Wang, et al.
Cardiovascular Diabetology
|
February 21, 2025
Association of glucagon-like peptide-1 receptor agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients
Li-Chun Lin, Jui-Yi Chen, Thomas Tao-Min Huang, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 83) with videos related to
Sort By:
Page
of 9
Frontiers in Pharmacology
|
May 29, 2026
Efficacy of combined sodium-glucose cotransporter 2 inhibitors and finerenone in chronic kidney disease: a systematic review and meta-analysis
Chen-Fu Wen, Min-Hsiang Chuang, Vin-Cent Wu, et al.
Geroscience
|
May 8, 2026
Comparative effectiveness of SGLT-2 inhibitors and GLP-1 receptor agonists on the risk of incident dementia after acute kidney injury: a target-trial emulation
Ying-Ru Chen, Zheng-Hong Jiang, Jui-Yi Chen, et al.
Cardiovascular Diabetology
|
July 31, 2024
Mortality and cardiovascular events in diabetes mellitus patients at dialysis initiation treated with glucagon-like peptide-1 receptor agonists
Hsuan-Wen Lai, Chun Yin See, Jui-Yi Chen, et al.
Scientific Reports
|
December 13, 2023
Lower product of magnesium × potassium is associated with higher mortality in chronic hemodialysis patients: a cohort study
Jui-Yi Chen, Ming-Yan Jiang, Yun-Ting Huang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 13, 2024
Enhanced Outcomes in Type 2 Diabetes Patients with Acute Kidney Disease Through Thiazolidinedione
Li-Yang Chang, Hung-Wei Liao, Jui-Yi Chen, et al.
Cardiovascular Diabetology
|
March 8, 2025
Potential benefits of GLP-1 receptor agonist in dialysis patients with type 2 diabetes: the need for comprehensive pharmacokinetic and hemodialysis analyses
Hsuan-Wen Lai, Jui-Yi Chen, Vin-Cent Wu, et al.
Kidney Research and Clinical Practice
|
February 5, 2026
Medical treatment for diabetic acute kidney disease from 2012 to 2024: advances, prescription trends, and future directions
Heng-Chih Pan, Chung-An Wang, Jui-Yi Chen, et al.
Diabetes Research and Clinical Practice
|
June 28, 2025
Clinical outcomes in people with type 2 diabetes and acute kidney disease: combined SGLT2i and GLP-1RA therapy vs. monotherapy
Jui-Yi Chen, Min-Hsiang Chuang, Hsuan-Wen Lai, et al.
International Journal of Molecular Sciences
|
February 10, 2024
From Acute to Chronic: Unraveling the Pathophysiological Mechanisms of the Progression from Acute Kidney Injury to Acute Kidney Disease to Chronic Kidney Disease
Tzu-Hsuan Yeh, Kuan-Chieh Tu, Hsien-Yi Wang, et al.
Cardiovascular Diabetology
|
February 21, 2025
Association of glucagon-like peptide-1 receptor agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients
Li-Chun Lin, Jui-Yi Chen, Thomas Tao-Min Huang, et al.
Page
of 9